Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature
Authors
Keywords
HE4, Ovarian cancer, Ovarian cancer recurrence
Journal
MEDICAL ONCOLOGY
Volume 34, Issue 9, Pages -
Publisher
Springer Nature
Online
2017-08-20
DOI
10.1007/s12032-017-1026-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of biomarkers in the management of epithelial ovarian cancer
- (2017) Wei-Lei Yang et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer
- (2017) Francesco Plotti et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset
- (2017) Francesco Plotti et al. MEDICAL ONCOLOGY
- Preoperative local staging of endometrial cancer: the challenge of imaging techniques and serum biomarkers
- (2016) Roberto Angioli et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4
- (2016) Stella Capriglione et al. Expert Review of Anticancer Therapy
- A Predictive Score for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer (SeC-Score): A Single-Centre, Controlled Study for Preoperative Patient Selection
- (2015) Roberto Angioli et al. ANNALS OF SURGICAL ONCOLOGY
- Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
- (2015) Donal J Brennan et al. BMC CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program
- (2015) Roberto Angioli et al. TUMOR BIOLOGY
- Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study
- (2015) Stella Capriglione et al. TUMOR BIOLOGY
- Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer?
- (2014) Roberto Angioli et al. TUMOR BIOLOGY
- Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma
- (2013) Sami K. Saarelainen et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- REM (Risk of Endometrial Malignancy): A Proposal for a New Scoring System to Evaluate Risk of Endometrial Malignancy
- (2013) R. Angioli et al. CLINICAL CANCER RESEARCH
- Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review
- (2013) Simona Ferraro et al. JOURNAL OF CLINICAL PATHOLOGY
- A critical review on HE4 performance in endometrial cancer: where are we now?
- (2013) Roberto Angioli et al. TUMOR BIOLOGY
- The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients
- (2013) Beyhan Omer et al. TUMOR BIOLOGY
- Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome
- (2012) Laura Zanotti et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- HE4 is an independent prognostic marker in endometrial cancer patients
- (2012) Irene Mutz-Dehbalaie et al. GYNECOLOGIC ONCOLOGY
- Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma?
- (2012) Roberto Angioli et al. GYNECOLOGIC ONCOLOGY
- The role of novel biomarker HE4 in endometrial cancer: a case control prospective study
- (2012) Roberto Angioli et al. TUMOR BIOLOGY
- Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer
- (2012) Teresa Granato et al. TUMOR BIOLOGY
- Does HE4 have a role as biomarker in the recurrence of ovarian cancer?
- (2012) Francesco Plotti et al. TUMOR BIOLOGY
- Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
- (2011) E Bignotti et al. BRITISH JOURNAL OF CANCER
- Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125
- (2011) Michèl Schummer et al. GYNECOLOGIC ONCOLOGY
- Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer
- (2011) Eleftheria Kalogera et al. GYNECOLOGIC ONCOLOGY
- Development of an ovarian cancer screening decision model that incorporates disease heterogeneity
- (2010) Laura J. Havrilesky et al. CANCER
- HE4: a new potential early biomarker for the recurrence of ovarian cancer
- (2010) Emanuela Anastasi et al. TUMOR BIOLOGY
- Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence
- (2008) Laura J. Havrilesky et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now